Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Dermatol. 2012 Apr 9;39(7):617–624. doi: 10.1111/j.1346-8138.2012.01553.x

Figure 3. A single treatment with decitabine induces expression of endogenous OCT4, mir-145, and mir-302c in HSKs.

Figure 3

qPCR data from decitabine-treated HSKs were normalized to untreated HSK controls, which were arbitrarily set at 1.00. Decitabine treatment yields ~4.5-fold increase in OCT4, ~3-fold increase in mir-145, and ~2-fold increase in mir-302c expression over untreated control. n = 3 for each group.